These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 19683621)
1. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma. Flucke U; Slootweg PJ; Mentzel T; Pauwels P; Hulsebos TJ Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621 [No Abstract] [Full Text] [Related]
2. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917 [TBL] [Abstract][Full Text] [Related]
3. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928 [TBL] [Abstract][Full Text] [Related]
4. [Molecular genetics and immunophenotype of INI1/SMARCB in epithelioid sarcoma]. Li L; Xia Q; Rao Q; Liu B; Wu B; Shi S; Yu B; Zhang R; Lu Z; Zhou X Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):389-93. PubMed ID: 25208989 [TBL] [Abstract][Full Text] [Related]
5. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas. Rekhi B; Vogel U APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315 [TBL] [Abstract][Full Text] [Related]
6. INI1-deficient tumors: diagnostic features and molecular genetics. Hollmann TJ; Hornick JL Am J Surg Pathol; 2011 Oct; 35(10):e47-63. PubMed ID: 21934399 [TBL] [Abstract][Full Text] [Related]
7. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma. Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682 [TBL] [Abstract][Full Text] [Related]
8. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions. Sullivan LM; Folpe AL; Pawel BR; Judkins AR; Biegel JA Mod Pathol; 2013 Mar; 26(3):385-92. PubMed ID: 23060122 [TBL] [Abstract][Full Text] [Related]
9. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR. Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366 [TBL] [Abstract][Full Text] [Related]
10. Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression. Kohashi K; Yamamoto H; Kumagai R; Yamada Y; Hotokebuchi Y; Taguchi T; Iwamoto Y; Oda Y Mod Pathol; 2014 Jun; 27(6):832-9. PubMed ID: 24287458 [TBL] [Abstract][Full Text] [Related]
11. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features. Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295 [TBL] [Abstract][Full Text] [Related]
12. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790 [TBL] [Abstract][Full Text] [Related]
13. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome. Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192 [TBL] [Abstract][Full Text] [Related]
14. Prognostic determinants in epithelioid sarcoma. Gasparini P; Facchinetti F; Boeri M; Lorenzetto E; Livio A; Gronchi A; Ferrari A; Massimino M; Spreafico F; Giangaspero F; Forni M; Maestro R; Alaggio R; Pilotti S; Collini P; Modena P; Sozzi G Eur J Cancer; 2011 Jan; 47(2):287-95. PubMed ID: 20932739 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre. Rekhi B; Jambhekar NA Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062 [TBL] [Abstract][Full Text] [Related]
16. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours. Rao Q; Xia QY; Wang ZY; Li L; Shen Q; Shi SS; Wang X; Liu B; Wang YF; Shi QL; Ma HH; Lu ZF; He Y; Zhang RS; Yu B; Zhou XJ Histopathology; 2015 Jul; 67(1):121-9. PubMed ID: 25496315 [TBL] [Abstract][Full Text] [Related]
17. Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor. Al-Hussaini M; Hirschowitz L; McCluggage WG Int J Gynecol Pathol; 2008 Apr; 27(2):236-42. PubMed ID: 18317218 [TBL] [Abstract][Full Text] [Related]
18. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049 [TBL] [Abstract][Full Text] [Related]
19. SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases. Folpe AL; Schoolmeester JK; McCluggage WG; Sullivan LM; Castagna K; Ahrens WA; Oliva E; Biegel JA; Nielsen GP Am J Surg Pathol; 2015 Jun; 39(6):836-49. PubMed ID: 25651469 [TBL] [Abstract][Full Text] [Related]
20. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]